ImpediMed

02/04/2026

Today is World Cancer Day, a global initiative led by the Union for International Cancer Control.

This year’s campaign theme, , puts people — not diagnoses — at the center of cancer care.

The message is simple: every experience of cancer is different, and care systems should reflect that.

Around the world, clinicians, advocates, survivors, and caregivers are sharing their stories to push for more people-centred, compassionate, and equitable care — during treatment and long after it ends.

Learn more about the United by Unique campaign and the global impact of World Cancer Day here: 🔗 https://www.worldcancerday.org/

01/28/2026

Exercise is widely recognized as beneficial in cancer care—but it’s still too often treated as a recommendation rather than a prescription.

In a recent MedCity News article, Maureen McBeth explores why movement needs to become a standard, structured part of cancer treatment and survivorship—not a wellness add-on—and what’s missing to make that shift possible.

The piece looks at the evidence, the implementation gap, and the role of personalized, data-informed approaches in supporting safe, effective exercise as part of care.

Read the full article here: https://www.impedimed.com/making-exercise-a-standard-in-cancer-survivorship-care/

01/23/2026

In a new piece for Physician’s Weekly, Steven Chen, MD, MBA argues that breast cancer care can’t stop at eliminating disease.

With more than 4 million people in the U.S. living after a breast cancer diagnosis, effective care means anticipating what comes next — including long-term physical effects, functional decline, and financial toxicity — from the very start of the care journey.

The article makes the case for moving from reactive to anticipatory care, with earlier conversations around survivorship risks, quality of life, and long-term health.

🔗 Read the full article here: https://www.impedimed.com/taking-charge-of-the-cost-conversation-practical-steps-for-patients-and-care-teams/

01/20/2026

January is often when care teams pause and reset.

It’s also a good time to revisit the basics:

- What does the SOZO® Digital Health Platform do?
- How does bioimpedance spectroscopy (BIS) work?
- What can patients expect from monitoring?

We pulled together the most common questions we hear and paired them with clear, straightforward answers.

Swipe to review the essentials — or visit the full FAQ page to learn more: https://www.impedimed.com/support/frequently-asked-questions/

01/15/2026

As GLP-1 use continues to expand, accurate clinical context matters.

In a recent KUTV segment on misleading weight-loss advertising, Maureen L. McBeth, Senior Medical Affairs Liaison at ImpediMed, shared a clinician’s perspective on the importance of medically supervised care and objective insight when patients are using therapies.

The coverage highlights why responsible communication, multidisciplinary support, and data-driven decision-making are critical as new therapies become more widely used.

Watch the full segment: https://www.impedimed.com/utah-ag-joins-30-plus-states-urging-meta-to-crack-down-on-misleading-weight-loss-ads/.

01/13/2026

“How often should someone with lymphedema be monitored?”

It’s a question that comes up frequently — from patients and care teams alike.

In this clip from Living Beyond Breast Cancer’s Innovations in Breast Cancer Care webinar series, Dr. Monique Gary shares how monitoring cadence is typically approached in practice, including how often tools like SOZO are used.

Clear, practical guidance like this helps set expectations and supports more consistent long-term care planning.

🎥 Clip from LBBC’s September webinar series
🎙️ Speaker: Monique Gary, DO, MSc, FACS

01/10/2026

📹 CBS 6 News highlighted how VCU Massey Comprehensive Cancer Center is bringing earlier, more precise screening into breast cancer survivorship care through bioimpedance spectroscopy (BIS).

Chief of Breast Surgery Dr. Kandace McGuire shares why identifying changes before swelling appears can make a meaningful difference for long-term quality of life—and why traditional limb measurements often detect lymphedema only after symptoms begin.

Watch for a clear look at how leading centers are strengthening proactive models of care:

Chief of Breast Surgery Dr. Kandace McGuire shares why identifying changes before swelling appears can make a meaningful difference for long-term quality of life—and why traditional limb measurements often detect lymphedema only after symptoms begin. Read Now

01/07/2026

January is when many care teams step back and ask a practical question: how should we be monitoring patients this year?

There isn’t a single right answer — it depends on what your team is tracking and how care is organized.

If you’re planning for 2026, these are three common starting points to explore:

➡️ Early detection of fluid change
L-Dex® analysis for lymphedema
https://www.impedimed.com/products/tissue-fluid-applications/l-dex-analysis-for-lymphedema/

➡️ Body composition change
Body composition analysis
https://www.impedimed.com/products/tissue-fluid-applications/body-composition-analysis/

➡️ Program structure and follow-up
Lymphedema Prevention Program (LPP)
https://www.impedimed.com/products/programs/lymphedema-prevention-program/

Each supports a different part of longitudinal monitoring — teams often start with the one that best matches their immediate needs.

01/01/2026

As we prepare for the year ahead, we’re reflecting on how far survivorship care has come — and the collaborations, research, and clinical leadership that continue to drive meaningful change.

From expanding prospective monitoring programs to strengthening accreditation-aligned workflows, 2025 brought major steps forward in breast-cancer–related lymphedema care. We’re grateful to everyone who contributed to this momentum.

Wishing you a bright start to the new year. We look forward to continuing this work together in 2026.

12/26/2025

As we enter the final days of the year, we’re reflecting on the people who make progress in survivorship care possible — clinicians, navigators, researchers, advocates, partners, and survivors.

Your work strengthens patient support, raises the standard for lymphedema care, and brings clarity and compassion to every step of treatment and recovery.

Wishing everyone a restorative and peaceful holiday season. Thank you for your commitment to the communities you serve.

12/22/2025

“We went back to my baseline measurements… it wasn’t until the fluid machine measured that change that we knew we had to act quickly.” — Keelin McDermott, breast cancer survivor

In LBBC’s recent webinar Lymphedema: Early Action & Long-Term Care, patient advocate Keelin shared how prospective monitoring and objective fluid data helped her care team understand what was changing in her arm — even before swelling was visible.

Her experience highlights why baseline data, early conversations, and clear protocols matter in navigating breast-cancer–related lymphedema with confidence rather than uncertainty.

Thank you to Keelin, Dr. Monique Gary, and Living Beyond Breast Cancer for leading this essential conversation.

12/15/2025

Exercise oncology and lymphedema care are often discussed separately — but they shouldn’t be.

In a new Urban Health Today interview, ImpediMed’s Maureen McBeth, PT, MPT, CLT-LANA, breaks down why integrated survivorship pathways matter, from exercise implementation gaps to the realities of breast cancer–related lymphedema.

She highlights the growing evidence base (including new NEJM data), the infrastructure barriers that still limit adoption, and how early detection tools like BIS can support personalized, preventive care.

If you’re building or expanding your survivorship program, this conversation is worth a listen.

🔗 https://www.impedimed.com/maureen-mcbeth-on-integrating-exercise-and-lymphedema-care/